Literature DB >> 26646440

[Modern diagnosis of sexually transmitted diseases].

N H Brockmeyer1, T Meyer2.   

Abstract

Diagnosis of sexually transmitted diseases (STD) has significantly improved in recent years by the application of nucleic acid amplification tests (NAAT). In addition to detection of infectious agents, molecular methods were also used for characterization of pathogens (typing, genotypic resistance testing). In contrast to conventional Sanger sequencing of amplicons, new sequencing technologies (next generation sequencing) are able to identify resistant variants that represent only small minorities in a heterogeneous population. NAATs are also available as fully automated closed systems that can be run independently of centralized laboratories and will become increasingly important for point-of-care testing.

Keywords:  Drug resistance; High-throughput nucleotide sequencing; Nucleic acid amplification techniques; Point of care; Typing

Mesh:

Year:  2016        PMID: 26646440     DOI: 10.1007/s00105-015-3726-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  26 in total

Review 1.  Antiviral resistance testing.

Authors:  Erasmus Smit
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

2.  Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.

Authors:  S W Peterson; I Martin; W Demczuk; A Bharat; L Hoang; J Wylie; V Allen; B Lefebvre; G Tyrrell; G Horsman; D Haldane; R Garceau; T Wong; M R Mulvey
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

3.  Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test.

Authors:  Barbara Van Der Pol; Terri Warren; Stephanie N Taylor; Mark Martens; Keith R Jerome; Leandro Mena; Joel Lebed; Savita Ginde; Paul Fine; Edward W Hook
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

Review 4.  Nucleic acid tests for the detection of alpha human papillomaviruses.

Authors:  Mario Poljak; Jack Cuzick; Boštjan J Kocjan; Thomas Iftner; Joakim Dillner; Marc Arbyn
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

Review 5.  Sensitivity, specificity and likelihood ratios of PCR in the diagnosis of syphilis: a systematic review and meta-analysis.

Authors:  Angèle Gayet-Ageron; Stephan Lautenschlager; Béatrice Ninet; Thomas V Perneger; Christophe Combescure
Journal:  Sex Transm Infect       Date:  2012-09-28       Impact factor: 3.519

6.  Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.

Authors:  Philip E Castle; Barbara Eaton; Jennifer Reid; Damon Getman; Janel Dockter
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

7.  Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Charlotte A Gaydos; Barbara Van Der Pol; Mary Jett-Goheen; Mathilda Barnes; Nicole Quinn; Carey Clark; Grace E Daniel; Paula B Dixon; Edward W Hook
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

8.  Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing.

Authors:  Simon R Harris; Ian N Clarke; Helena M B Seth-Smith; Anthony W Solomon; Lesley T Cutcliffe; Peter Marsh; Rachel J Skilton; Martin J Holland; David Mabey; Rosanna W Peeling; David A Lewis; Brian G Spratt; Magnus Unemo; Kenneth Persson; Carina Bjartling; Robert Brunham; Henry J C de Vries; Servaas A Morré; Arjen Speksnijder; Cécile M Bébéar; Maïté Clerc; Bertille de Barbeyrac; Julian Parkhill; Nicholas R Thomson
Journal:  Nat Genet       Date:  2012-03-11       Impact factor: 38.330

9.  Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.

Authors:  Alessandro Cozzi-Lepri; Marc Noguera-Julian; Francesca Di Giallonardo; Rob Schuurman; Martin Däumer; Sue Aitken; Francesca Ceccherini-Silberstein; Antonella D'Arminio Monforte; Anna Maria Geretti; Clare L Booth; Rolf Kaiser; Claudia Michalik; Klaus Jansen; Bernard Masquelier; Pantxika Bellecave; Roger D Kouyos; Erika Castro; Hansjakob Furrer; Anna Schultze; Huldrych F Günthard; Francoise Brun-Vezinet; Roger Paredes; Karin J Metzner
Journal:  J Antimicrob Chemother       Date:  2014-10-21       Impact factor: 5.790

10.  Comparing the performance of six human papillomavirus tests in a screening population.

Authors:  J Cuzick; L Cadman; D Mesher; J Austin; L Ashdown-Barr; L Ho; G Terry; S Liddle; C Wright; D Lyons; A Szarewski
Journal:  Br J Cancer       Date:  2013-01-31       Impact factor: 7.640

View more
  1 in total

Review 1.  [Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads].

Authors:  P Nenoff; A Manos; I Ehrhard; C Krüger; U Paasch; P Helmbold; W Handrick
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.